1.The Assessment of Diazepam as Hypnotie on the Night Before Operation .
Korean Journal of Anesthesiology 1976;9(2):271-276
The hypnotic activity of diazepam was compared with that of inactive placebo in a double- blind, randomized study in 40 surgical patients the night before their scheduled procedures. Diazepam per os (10mg) produces a pattern of response that differed markedly from that of the placebo. The patient receiving diazepam fell asleep sooner, slept more soundly and steadily and more felt they had been helped to sleep, while fewer awoke during the night. The significant difference Was obtained in both hypnotic and ataractic effects between diazepam and inactive placebo. Neither diaxepam nor inactive placbo caused marked changes in vital signs or any serious side effects.
Diazepam*
;
Humans
;
Vital Signs
2.Study on Month of Birth Based on 1998 Korean Vital Statistics.
Sang Hwa PARK ; Jung Hwa KIM ; Shin Yong MOON ; Seok Hyun KIM
Korean Journal of Perinatology 2001;12(3):290-294
No abstract available.
Parturition*
;
Vital Statistics*
3.Anesthetic Management for Bilateral Pheochromocytoma.
Chun Sub RHIM ; Hae Kyu KIM ; Seung Wan BAIK ; Inn Se KIM ; Kyoo Sub CHUNG
Korean Journal of Anesthesiology 1987;20(6):880-886
Pheochromocytoma is the cause of hypertension in 0.1% of the hypertencive patits, and in 10% of these cases, the tumor is bilateral. Therefore bilateral pheochromocytoma is very rare. The following is a report of the anesthetic methods employed in the surgical management of a case of bilateral pheochromocytoma which was performed in stages at PNUH, between June 4th and June 12, 1986. The staged operation reduced the instability of the vital signs caused by concurrent manipulation of the bilateral pheochromoytoma and facilitated tumor removal.
Hypertension
;
Pheochromocytoma*
;
Vital Signs
4.Anesthetic Management for Bilateral Pheochromocytoma.
Chun Sub RHIM ; Hae Kyu KIM ; Seung Wan BAIK ; Inn Se KIM ; Kyoo Sub CHUNG
Korean Journal of Anesthesiology 1987;20(6):880-886
Pheochromocytoma is the cause of hypertension in 0.1% of the hypertencive patits, and in 10% of these cases, the tumor is bilateral. Therefore bilateral pheochromocytoma is very rare. The following is a report of the anesthetic methods employed in the surgical management of a case of bilateral pheochromocytoma which was performed in stages at PNUH, between June 4th and June 12, 1986. The staged operation reduced the instability of the vital signs caused by concurrent manipulation of the bilateral pheochromoytoma and facilitated tumor removal.
Hypertension
;
Pheochromocytoma*
;
Vital Signs
5.Comparison of the Efficacy and Safety of the Unicenta and Melsmon Injection for the Menopausal Symptoms.
Seongmin KIM ; Hyun Tae PARK ; Byung Ik LEE ; Jung Ho SHIN ; Hyung Moo PARK ; Tak KIM
The Journal of Korean Society of Menopause 2013;19(1):36-44
OBJECTIVES: The objective of this study was to evaluate the efficacy of Unicenta (UNCNT) and Melsmon in women with the menopausal symptoms, by analysing the changes in the Kupperman index (primary endpoint), and the hormonal change (secondary endpoint). METHODS: This is a randomized, multi-Center, double-Blind, parallel, non-inferiority clinical study of four different tertiary medical centers. We began the participant recruitment in September 2011, with 218 patients applied over 7 months. All participants had the last visit in April 2012. RESULTS: The Unicenta injection was not inferior to that of Melsmon as measured by the Kupperman index following the injection in both the intent-to-treat and the per-protocol populations (P = 0.63, P = 0.85, respectively). Side effects occurred in 14.0% of the cases (15 patients/18 cases) in the case group, and in 12.6% (14 patients/15 cases) in the control group (P value=0.7599). None were reported to be associated with the medication. The laboratory results and the vital signs showed no statistically significant risk for safety. CONCLUSION: The study showed that Unicenta is not inferior to Melsmon in the change of the Kupperman index after 12 days of injection. The efficacy and safety of Unicenta was shown, with the improvement of the menopausal symptoms.
Female
;
Humans
;
Menopause
;
Vital Signs
6.Comparison of Midazolam Alone versus Midazolam Plus Propofol during Endoscopic Submucosal Dissection.
Young Shim CHO ; Euikeun SEO ; Jung Ho HAN ; Soon Man YOON ; Hee Bok CHAE ; Seon Mee PARK ; Sei Jin YOUN
Clinical Endoscopy 2011;44(1):22-26
BACKGROUND/AIMS: For proper sedation during endoscopic submucosal dissection (ESD), propofol has been widely used. This study aimed to compare the levels of sedation and tolerance of patients treated with midazolam (M group) and a combination of midazolam and propofol (MP group) during ESD. METHODS: A total of 44 consecutive patients undergoing ESD were randomly assigned to the two groups. In the M group, 2 mg of midazolam was given repeatedly to maintain after a loading dose of 5 mg. The MP group initially received 5 mg of midazolam and 20 mg of propofol. Then, we increased the dosage of propofol by 20 mg gradually. RESULTS: The average amount of midazolam was 12 mg in the M group. In the M group, 10 patients were given propofol additionally, since they failed to achieve proper sedation. The average amount of propofol was 181 mg in the MP group. Procedure time, vital signs and rates of complications were not significantly different between two groups. Movement of patients and discomfort were lower in the MP group. CONCLUSIONS: During ESD, treatment with propofol and a low dose of midazolam for sedation provides greater satisfaction for endoscopists compared to midazolam alone.
Humans
;
Midazolam
;
Propofol
;
Vital Signs
7.Comparison of Midazolam Alone versus Midazolam Plus Propofol during Endoscopic Submucosal Dissection.
Young Shim CHO ; Euikeun SEO ; Jung Ho HAN ; Soon Man YOON ; Hee Bok CHAE ; Seon Mee PARK ; Sei Jin YOUN
Clinical Endoscopy 2011;44(1):22-26
BACKGROUND/AIMS: For proper sedation during endoscopic submucosal dissection (ESD), propofol has been widely used. This study aimed to compare the levels of sedation and tolerance of patients treated with midazolam (M group) and a combination of midazolam and propofol (MP group) during ESD. METHODS: A total of 44 consecutive patients undergoing ESD were randomly assigned to the two groups. In the M group, 2 mg of midazolam was given repeatedly to maintain after a loading dose of 5 mg. The MP group initially received 5 mg of midazolam and 20 mg of propofol. Then, we increased the dosage of propofol by 20 mg gradually. RESULTS: The average amount of midazolam was 12 mg in the M group. In the M group, 10 patients were given propofol additionally, since they failed to achieve proper sedation. The average amount of propofol was 181 mg in the MP group. Procedure time, vital signs and rates of complications were not significantly different between two groups. Movement of patients and discomfort were lower in the MP group. CONCLUSIONS: During ESD, treatment with propofol and a low dose of midazolam for sedation provides greater satisfaction for endoscopists compared to midazolam alone.
Humans
;
Midazolam
;
Propofol
;
Vital Signs
8.Airway collapsibility indicating indication excessive airway narrowing in asthma.
Inseon CHOI ; Ho LIM ; Seon Yeong PARK ; Youngil I KOH ; Se Woong CHUNG
Journal of Asthma, Allergy and Clinical Immunology 2003;23(2):385-393
BACKGROUND: It has been sugested that excessive airway narrowing in asthma may be detected by a decrease in forced vital capacity (FVC). A volume differrence between slow vital capacity (SVC) and FVC may be used as a surrogate index of airway collapse. OBJECTIVE: To investigate the relationship between an airway collapsibility index (CI) and airflow limitation or airway hyperresponsiveness in asthma. METHODS: Forty-six patients with suspected asthma and 21 normal control subjects were enrolled. CI was defined as a difference between SVC and FVC, and measured before and after a methacholine (MCh) bronchoprovocation test. Positive response to MCh was defined as a fall of FEV1 by more than 12%. RESULTS: CI significantly increased from 1.10+/-3.86% to 5.52+/-7.91% after MCh in the positive MCh group (n=19, p<0.01). Not only FVC but also SVC was significantly decreased after MCh. One-fifth of the decrease in FVC was caused by the increase in CI. Both FVC and SVC were significantly related to baseline FEV1 values and in percent change after MCh. Although CI was also significantly related to FEV1 in percent change after MCh. CI was significantly higher in the positive MCh group than in the control and was not significantly related to baseline FEV1 values. Furthermore, the relationship of CI values between before and after MCh was significant (r=0.622, p<0.01). CI was not significantly different according to the severity of MCh-PC20. CONCLUSION: Because the relationship between CI and the severity of airflow limitation or MCh-PC20 was less significant. CI may be better than FVC to represent the characteristic of excessive airway narrowing in asthma.
Asthma*
;
Humans
;
Methacholine Chloride
;
Vital Capacity
9.A Case of Falling of Taiki from the Upper Aspect of the Body Caused by Taking a Kind of Cathartic Drug
Kampo Medicine 2009;60(5):533-537
Taiki is a kind of fundamental vital energy filling the upper aspect of the body, and it can fall because of stress, heavy labor, diarrhea, excessive intake of drugs for regulating the flow of vital energy, or extreme deficiency in vital energy.We report the case of a 39 year old female patient who complained of dyspnea, psychic enervation, and other symptoms of falling taiki from the upper aspect of the body, caused by taking a cathartic drug (mashiningan) for constipation, while being treated for agitation and emotional incontinence. Shokanto improved this state of falling taiki from the upper aspect of the body.
Energy, Physics
;
Vital
;
Cathartics
;
g <3>
;
Due to
10.A Case of Pheochromocytoma.
Chang Han YOUN ; Chong Keun RHEE ; Moo Sik AHN ; Sung Ryong CHO
Korean Journal of Urology 1984;25(6):795-798
We report a case of left adrenal pheochromocytoma in 17-year-old girl, we observed all of vital sign were returned to normal in 19-th postoperative day
Adolescent
;
Female
;
Humans
;
Pheochromocytoma*
;
Vital Signs